Position
Squarepoint Ops LLC in Madrigal Pharmaceuticals, Inc.
Back to the book · All holders of MDGL
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$3.11M$582.34 → $523.47
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 74.9K | $43.6M | — | — | — | 0.0% |
| Q1 2026 | 52.9K | $27.7M | $523.47 | −$3.11M | −$12.8M | 0.0% |